The objective of this study was to determine the antibiotic resistance amongst beta-haemolytic streptococci (BHS) from North India. A total of 155 BHS isolates, comprising group A streptococci (GAS) (102), group C streptococci (GCS) (25) and group G streptococci (GGS) (28), collected from patients with pharyngitis, rheumatic fever, skin disease and invasive disease were analysed for their antimicrobial susceptibility to 20 antibiotics using the Kirby-Bauer disc diffusion method. The MICs of penicillin, tetracycline, clarithromycin, azithromycin and erythromycin were also determined using the HiComb test, following the Clinical and Laboratory Standards Institute guidelines. The results showed that 37.4 % of BHS isolates were susceptible to all antibiotics and 19.4 % were highly resistant to tetracycline; however, only 2.6-5.2 % were resistant to macrolides. The tetracycline resistance (P,0.05) of BHS was found to be statistically significant. GAS isolates from different sources of infection also showed statistically significant antibiotic resistance to azithromycin (P50.029). Multi-drug resistance was found irrespective of streptococcal emm types. No association between GAS emm types and drug resistance was seen. MIC determination showed all isolates to be susceptible to the five antibiotics tested, except for two GAS and one GGS isolates that were resistant to clarithromycin, and one GAS skin isolate that was resistant to tetracycline. This study suggests that the variation in antibiotic resistance amongst BHS isolates from North India is independent of the isolation source and emm type distribution, hence emphasizing the need for a longitudinal surveillance in different regions of India.
INTRODUCTION
Beta-haemolytic streptococci (BHS) cause diseases worldwide, ranging from uncomplicated mild infections to severe life-threatening conditions. Amongst them, group A streptococci (GAS) cause serious illnesses such as scarlet fever, rheumatic fever (RF)/rheumatic heart disease (RHD) and severe invasive diseases. Group C and group G streptococci (GCS and GGS, respectively), genetically close relatives of GAS, also cause similar infections (Kittang et al., 2011; Lindbaek et al., 2005) . The burden of streptococcal disease is quite high worldwide. In India, RF/RHD are leading causes of acquired heart disease, though reports on streptococcal invasive diseases are also emerging (Mathur et al., 2002) . However, to date there is no effective vaccine available and currently all the global efforts for preventing streptococcal diseases, especially RF/RHD, rely on an accurate diagnosis followed by appropriate secondary prophylaxis.
Penicillin and its derivatives, cephalosporins, macrolides and clindamycin are effectively used in treating pharyngitis. Though there are some reports showing failure in penicillin treatment against GAS infections, no resistant clinical isolate has been identified so far. In children oral amoxicillin is often used and erythromycin is used for patients allergic to or showing non-compliance to penicillin. In recurrent infections, clindamycin and amoxicillin-clavulanate are used to prevent infection (Bisno & Kaplan, 2002) . GAS have developed resistance to sulfonamides, tetracycline and erythromycin worldwide, which is attributed to their increased prescription (Capoor et al., 2006; Erdem et al., 2005) . However, the rationale is that GAS still remain uniformly susceptible to penicillin in spite of well-documented penicillin resistance in other Gram-positive, closely related species, such as Streptococcus pneumoniae, viridans streptococci and Enterococcus species.
Comprehensive information on the antimicrobial resistance pattern in the streptococci that cause a wide array of infections, particularly RF and invasive disease, is lacking in India (Brahmadathan et al., 2005; Capoor et al., 2006; Ray et al., 2010) . Due to the value of penicillin for treatment in a cost-effective manner, and the emergence of new antibioticresistant strains in a community, the present study was designed to closely monitor the resistance pattern of BHS clinical isolates obtained from different streptococcal diseases in the Indian population to 20 available antibiotics, which have pathogenetic, clinical and public health relevance. We also sought to define whether any specific GAS emm type is associated with resistance to a specific antibiotic.
METHODS
Strains and culture conditions. A total of 155 BHS strains were isolated from individuals with (and without) pharyngitis, with impetigo, RF and invasive disease, and were collected at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, during community screening in and around Chandigarh, Punchkula district Haryana and Roopnagar district Punjab, over the course of 8 years (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) ; these strains were selected randomly. These isolates were collected from the throat, skin and blood samples of patients, after they had given informed consent. Ethical approval was obtained from the PGIMER Ethics Committee, Chandigarh. Samples were streaked onto blood agar, Chandigarh plates supplemented with 5 % sheep blood and were incubated at 37 uC for 24 h in 5 % CO 2 to check for the presence of BHS. Lancefield grouping of pure cultures was carried out using a Streptex kit (Murex Biotech). BHS strains were stored at 270 uC and were subcultured prior to testing.
emm Typing. emm Typing of GAS isolates was carried out according to standard laboratory procedures. The sequences were analysed using the BLAST program (http://www.ncbi.nlm.nih.gov) of the National Center for Biotechnology Information and were reconfirmed by submission to the Centers for Disease Control and Prevention.
Disc diffusion method. The Kirby-Bauer disc diffusion test was performed according to the Clinical and Laboratory Standards Institute (CLSI) procedures. An inoculum (0.5 McFarland standard) of selected isolates, which were incubated overnight, was spread evenly over the 200 mm Mueller-Hinton agar plates supplemented with 5 % sheep blood and was air-dried. Discs containing specific concentrations of 20 antibiotics were applied onto the surface of agar plates (see Table 2 ). The antibiotics used were cephalothin, clindamycin, co-trimoxazole, erythromycin, gentamicin, ofloxacin, penicillin, vancomycin, ampicillin, chloramphenicol, oxacillin, linezolid, azithromycin, amikacin, clarithromycin, teicoplanin, meticillin, amoxyclav, novobiocin and tetracycline. Plates were incubated at 37 uC in 5 % CO 2 for 24 h. Zone diameters of bacterial growth inhibition from 10 to 40 mm were measured using the HiMedia Antibiotic Zone scale. The strains were designated sensitive, intermediately susceptible (IS) or resistant, according to CLSI guidelines (CLSI, 2012 Quality control. The quality control strain S. pneumoniae (ATCC 49619) was included in each test and results were accepted only if they were within the CLSI-specified ranges.
Media, chemicals and antimicrobial agents. All chemicals and media used for culturing BHS, the antibiotic discs and the HiComb strips were obtained from HiMedia Laboratories. The emm-sequencing reagents were obtained from Applied Biosystems.
Statistical methods. Zone size was interpreted in accordance with the guidelines provided by the CLSI, 2012, as per manufacturer's instructions (Rowe et al., 2009) . The criteria specific for streptococci were followed for all antibiotics in the disc diffusion assay, except for novobiocin, meticillin, gentamicin, amikacin and teicoplanin, for which only general criteria were followed. The antibiotic resistance rates were compared by using a chi-squared test. A P-value of ,0.05 was considered statistically significant. The number of resistant versus sensitive strains was compared for two individual antibiotics using Fisher's Exact test and the two tail P-values were depicted.
RESULTS
From the randomly selected 155 BHS isolates, 102 were GAS (65.8 %), 25 were GCS (16 .1%) and 28 were GGS (18 .1%). The 102 GAS isolates were from different clinical groups: with/without pharyngitis (n539), skin disease (n539), RF (n59) and invasive disease (n515). Amongst non-group A isolates, 18 GCS and 23 GGS were from throat cultures, and seven GCS and five GGS isolates were from skin cultures. Table 1 shows the distribution of emm types/subtypes of GAS isolates collected from patients with different streptococcal infections. Accordingly, 102 GAS isolates were further categorized into 40 GAS emm types/subtypes, and were checked for their antibiotic susceptibility. Table 2 shows the antibiotic susceptibility pattern of BHS isolates, as determined by the disc diffusion method. A total of 37.4 % (58/155) BHS isolates, 31.4 % (32/102) of GAS, 40 % (10/25) of GCS and 57.1 % (16/28) of GGS isolates, were sensitive to all the antibiotics. BHS showed the highest number of resistant isolates (19.4 %, 30/155) to tetracycline, and the proportion of resistant isolates to the other antibiotics ranged between 0.6 and 5.2 %.
GAS isolates showed resistance to 12 antibiotics (60 % of the antibiotics tested, 12/20), as compared with GCS and GGS isolates that showed resistance to only five (25 % of antibiotics) and three (15 %) antibiotics, respectively. GAS showed the highest number of isolates resistant (25.5 %) to tetracycline, followed by 13.7 % of isolates resistant to novobiocin, 7.8 % to azithromycin, 4.9 % to clarithromycin and 3.9 % to both chloramphenicol and amikacin. Though GAS were resistant to clindamycin, ampicillin, co-trimoxazole and gentamicin, GCS and GGS were susceptible to these antibiotics. GCS had the highest proportion of isolates resistant (28 %) to novobiocin, followed by 20 % of strains resistant to amikacin, 8 % to chloramphenicol and 4 % to both clarithromycin and tetracycline, whereas 10.7 % of GGS isolates were resistant to tetracycline, 7.1 % to novobiocin and 3.6 % to amikacin.
Additionally, IS BHS isolates were also observed for 19 of the 20 antibiotics tested; GAS, GCS and GGS were IS to 17, 11 and 13 antibiotics, respectively. GAS showed the highest proportion of isolates IS (28.4 %, 29 isolates) to novobiocin, followed by 15.7 % (16) of isolates that were IS to clarithromycin and only one isolate was IS to penicillin. GCS showed the highest proportion of IS isolates (24 %, 6 isolates each) to penicillin and ampicillin, and GGS (17.9 %) showed the highest proportion of IS isolates to novobiocin. All BHS showed statistically significant antibiotic resistance to tetracycline (P50.023) and amikacin (P50.01) (Fig. 1 ).
GAS isolates collected from different types of infection were sensitive to ofloxacin, linezolid, amoxyclav, cephalothin, meticillin, oxacillin, vancomycin and teicoplanin (Fig. 2) . Of the GAS that were cultured, 43.6 % (17/39) of throat isolates, 25.6 % (10/39) of skin isolates, no RF isolates and 33.3 % (5/ 15) of invasive disease isolates were susceptible to all antibiotics. GAS isolated from the throat and skin showed the highest proportion of isolates (17.9 and 30.8 % of isolates, respectively) resistant to tetracycline; GAS isolated from RF patients were resistant to four antibiotics (33.3 % of isolates showed resistance to tetracycline, 22.2 % to both novobiocin and co-trimoxazole, and 1 % to amikacin) and a high number of GAS isolates from patients with invasive disease was resistant (26.7 % of isolates) to tetracycline, followed by 13.3 % of isolates that were each resistant to amikacin and novobiocin. GAS isolated from different sites showed statistically significant antibiotic resistance to novobiocin (P50.01), co-trimoxazole (P50.002) and azithromycin (P50.029). In GCS, two out of 18 throat isolates showed resistance to novobiocin, and one showed resistance to amikacin, while skin isolates were resistant to five antibiotics, in order of the number of resistant isolates, novobiocin (5/7), amikacin (4/7), chloramphenicol (2/7), clarithromycin (1/7) and tetracycline (1/7). GGS isolated from skin infections showed resistance (1/5) to only novobiocin, while only a few throat isolates showed resistance (3/23) to tetracycline.
Multi-drug resistance was also observed in BHS isolates. A total of 20.6 % (21/102) of GAS isolates -7.6 % (3/39) of pharyngitis isolates, 33 % (13/39) of skin isolates, 22 % (2/9) of RF isolates and 20 % (3/15) of invasive disease isolateswith different emm types showed this feature (Table 3) . Multi-drug resistance was most frequent in skin isolates. The emm 11 type found in pharyngitis and RF isolates, the emm 85 type found in pharyngitis and skin isolates, and interestingly, six emm 44 types found in skin isolates showed quite a different pattern of multi-drug resistance. In the case of GCS, three skin isolates showed resistance to novobiocin and amikacin, and one was resistant to chloramphenicol, clarithromycin, novobiocin and tetracycline, while only one GGS throat isolate was resistant to novobiocin and amikacin, and was IS to ampicillin, clarithromycin, amoxyclav, tetracycline, oxacillin and gentamicin.
We further analysed the association of GAS emm types with antibiotic resistance. The emm types 4. 2, 57, 75.1, 22, 103, 112.2, 1.2b, 11, 44, 12.17, 80, 77, 85, 11.1, 70, 81.2, 95, 109.1, 79 .1 and 63 were sensitive to all the antibiotics. All the emm 11 and 75.1 isolates were sensitive to macrolides, as compared with emm types 12, 44, 112.2 and 81. The emm type 11 isolates showed different susceptibility patterns; skin isolates were sensitive to 20 antibiotics, RF isolates were resistant to novobiocin and tetracycline, and pharyngitis isolates were resistant to penicillin, chloramphenicol, ampicillin and tetracycline. Isolates with type emm 44 from pharyngitis and skin infections also differed greatly in their susceptibility patterns, as the throat isolates were sensitive to linezolid, novobiocin, erythromycin, cotrimoxazole, azithromycin and meticillin; however, a high number of skin isolates were either IS or resistant to these antibiotics. A high number of emm type 112.2 strains Results of HiComb MIC testing of one GAS and six GCS isolates that were IS to penicillin using the disc diffusion method demonstrated that they were all susceptible to penicillin, but had raised penicillin MIC values of 0.512 and 0.032-0.256 mg ml 21 for GAS and GCS, respectively. BHS isolates that were resistant and IS to erythromycin (4 and 3, respectively) and azithromycin (8 and 8, respectively) were all susceptible, with MIC values ranging from 0.0001 to 0.1 mg ml
21
. Two GAS and one GGS isolates were resistant to clarithromycin, with MICs of 1 and 4 mg ml 21 , respectively. All BHS isolates that were tested for tetracycline MIC values were susceptible, except for one GAS skin isolate which had a tetracycline MIC value of 10 mg ml
.
DISCUSSION
Streptococcal infections are primarily treated based on the likely pathogens and their antibiotic susceptibility, hence the vigilance of antimicrobial resistance patterns of BHS to various antibiotics is of the utmost importance. The present comprehensive study provides a unique opportunity to address the antibiotic susceptibility of GAS, GCS and GGS isolated from different clinical sources to generally prescribed drugs in the local region.
Antibiotic susceptibility testing of GAS using the disc diffusion method in the present study showed that no isolate was resistant to penicillin; however, one was IS to it, reinforcing the fact that penicillin resistance has not developed in North India, despite its frequent use, which is in agreement with worldwide data (Aggarwal et al., 1984; Macris et al., 1998; Navaneeth et al., 2001; Rowe et al., 2009 ).
In the present study, GAS were generally susceptible to antimicrobial agents except macrolides and tetracycline; these data are similar to previous findings (Inoue et al., 2008) . Worldwide data suggest an increased resistance of GAS to macrolides, ranging from 0. A Cd E At Cw T C Nv Ak G Throat isolates 11 + 2 2 2 2 2 + 2 2 2 57 2 2 2 + + + 2 2 2 2 85 2 + + 2 2 2 2 2 2 2 Skin isolates 12 2 2 2 2 + 2 + + 2 2 22.8 2 2 2 + 2 2 + 2 2 2 44 2 2 2 + 2 2 2 + 2 2 44 + 2 2 + 2 + 2 2 2 2 44 2 2 + 2 2 2 2 + 2 2 44 2 2 2 + 2 2 2 + 2 2 44 2 2 2 + + + 2 + 2 2 44 2 2 2 2 2 2 2 2 2 2 49 2 2 2 + + + 2 2 2 2 75.1 2 2 2 2 2 + 2 + 2 2 81 2 2 + 2 2 2 2 2 + 2 81 2 2 2 2 2 + 2 + 2 + 85 2 2 2 2 2 + 2 + 2 2 RF isolates 11 2 2 2 2 2 + 2 + 2 2 67 2 2 2 2 2 + 2 + 2 2 Invasive disease isolates 58 2 2 2 2 2 + + 2 2 2 87 2 2 + 2 2 + 2 2 + 2 95 2 2 2 2 2 + 2 + + 2 Rowe et al., 2009; Traub & Leonhard, 1997) ; a review of Indian literature showed a gradual increase upto 29.4 % up until 2010 (Brahmadathan et al., 2005; Capoor et al., 2006; Dhakal et al., 2010; Lloyd et al., 2007; Mathur et al., 2002) . The absence of, or very low, erythromycin resistance among GAS from pharyngitis and RF patients in the present study is quite similar to previous findings (Brahmadathan et al., 2005; Rijal et al., 2009) . Moreover, the low number of GAS isolates (only 2.9 %) IS to erythromycin might be a consequence of the relatively infrequent use of erythromycin by local practitioners, who tend to prescribe penicillin to treat streptococcal infections. These therapy choices are favourable in our community, as there is a mild risk in prescribing erythromycin to patients allergic to penicillin. We observed a high percentage of GAS isolates resistant to azithromycin, which is structurally related to erythromycin and clarithromycin, and so these antibiotics are not preferred over erythromycin.
The high resistance (25.5 %) of GAS to tetracycline reported here is comparable to the global rise noticed (Aggarwal et al., 1984; Dhakal et al., 2010; Jain et al., 2008; Lloyd et al., 2007; Ray et al., 2010; Smeesters et al., 2010; Traub & Leonhard, 1997; Zaoutis et al., 1999) that has been assigned to polyclonal dissemination of resistance types, as antibiotic resistance encoded by transposable elements does occur in GAS. GAS resistance (3.9 %) to chloramphenicol and susceptibility to vancomycin reported in this study are similar to results from previous reports (Jain et al., 2008) . We found that only 2.9 % of GAS isolates were resistant to co-trimoxazole, as compared with 12.2 % reported in Lucknow, India (Jain et al., 2008) . Though resistance to co-trimoxazole was low, co-trimoxazole cannot be used because of the intrinsic resistance in GAS. Our BHS isolates were either resistant or IS to beta-lactam antibiotics, cephalosporins, linezolid, clindamycin and chloramphenicol, though with very low frequencies as compared with previous reports in India (Capoor et al., 2006; Lloyd et al., 2007) .
When the antibiotic susceptibility of GAS was compared with the site of infection, GAS isolates from skin infections in the present study showed comparable antibiotic resistance to a sentinel surveillance from Kolkata, India; resistance to tetracycline (52.2 %, our data 30.8 %) and resistance to erythromycin (3.5 %, our data 5.1 %), even intermediate susceptibility to erythromycin (6.9 %, our data 5.1 %), were comparable (Ray et al., 2010) . No skin isolate resistant to penicillin was found, so penicillin is still the first choice for treatment of erysipelas; however, complicated skin and soft tissue infections require broad spectrum antibiotics. GAS isolated from RF patients showed resistance to only four antibiotics, with maximum resistance to co-trimoxazole; however, due to the paucity of such data, the results could not be compared.
All invasive disease GAS isolates in the present study were sensitive to penicillin, ampicillin and clindamycin, results that are similar to those from a previous report; however, high resistance (our data 26.7 %, 11 %) to tetracycline and (our data 6.7 %, 2.7 %) to erythromycin contrasted with an Australian report (Norton et al., 2004) . Even resistance to erythromycin was quite high compared with a previous report from North India (Mathur et al., 2002) . Erythromycin resistance in GAS isolates causing invasive disease was very similar to that found in GAS isolates causing skin infections (5.1 %), but it was higher than that found in isolates causing throat infections (2.6 %), suggesting that erythromycinresistant isolates from throat infections may not correspond to severe invasive GAS infections. Clindamycin and amikacin replace the empirically commenced broad specific antibiotics in necrotizing myositis, a case report from India (Bharathi et al., 2009) ; however, the amikacin resistance (13 %) reported here is a matter of concern.
Unlike GAS, the antibiotic-resistance attributes of both GCS and GGS have not previously been studied extensively. But with the emergence of these non-GAS associated with serious infections, such reports are appearing. In the treatment of Streptococcus dysgalactiae subsp. equisimilis (group C/G) pharyngitis infections, the most active antimicrobial agents used are penicillin, cephalosporin, carbapenem and vancomycin; however, reports on betalactam therapy failure and antimicrobial tolerance to these agents are now emerging (Savini et al., 2008; Zaoutis et al., 1999) . The intermediate susceptibility among the streptococci to penicillin in the present study is quite similar to results from a previous report, in which it was suggested that the susceptibility was entirely due to low-affinity penicillin-binding proteins and was not mediated by the expression of beta-lactamases. In the present study all GCS were susceptible to chloramphenicol, teicoplanin, cephalothin and vancomycin, and all GGS were susceptible to cephalothin, as already reported by Norton et al. (2004) . GCS and GGS resistance to tetracycline, chloramphenicol and macrolides, especially erythromycin and clindamycin, is now emerging (Kataja et al., 1998; Lloyd et al., 2007) . GCS and GGS sensitivity to erythromycin, and resistance to tetracycline, clindamycin and chloramphenicol are in contrast with published data (Kataja et al., 1998) . Hence the emergence of antibiotic resistance amongst GCS and GGS may be a matter of concern.
There are reports available in the literature that show multidrug resistance exhibited by enterococci, Staphylococcus aureus, Streptococcus pneumoniae and the viridans group etc., but to the best of our knowledge, to date there is no published report that focuses on BHS multi-drug resistance to the antibiotics used to combat streptococcal infections. Moreover, in India, such a pattern of co-resistance or multidrug resistance amongst GAS from different sources of infection has not been reported. The multi-drug resistance found in the present study might be due to the ease of availability of antibiotics from private practitioners or pharmacists and their irrational use. This issue needs to be addressed by propagating judicious use of antibiotics, continued surveillance studies and by focusing attention on developing an efficacious vaccine, especially in children (5-15 years of age) who are at high risk.
No link between emm types and antibiotic resistance could be drawn, as resistance seems to be isolate dependent. Though the distribution of GAS emm genotypes and their relationships with erythromycin and clindamycin resistance were very similar to a previous report, except for emm 12 and 77 (Koh et al., 2008) , we understand that we examined a population that is a microcosm for such a study.
To select an appropriate drug to treat streptococcal diseases, a comparison of antibiotic sensitivity between individual antibiotics is required. So when the sensitivity of GAS to penicillin and erythromycin, and to three macrolides, i.e. erythromycin, azithromycin and clarithromycin, was compared, no significant difference was found; however, when erythromycin and clarithromycin were compared individually, results were significant (P50.008). Hence, erythromycin can be considered a more appropriate drug after penicillin. GAS was sensitive to vancomycin, oxacillin, amoxyclav, cephalothin, ofloxacin, teicoplanin, linezolid and clindamycin (P50.000), as compared with tetracycline and novobiocin, hence these antibiotics can also be considered as effective drugs; however, erythromycin and penicillin are still the better drugs of choice for treating streptococcal infections.
All the streptococci were susceptible to the antibiotics that were tested using the MIC method, except for three isolates that were resistant to clarithromycin, and one isolate that was resistant to tetracycline. The penicillin MIC for GAS has not changed over time; however, increasing MICs for GCS and GGS have been reported, which can be linked to the extensive usage of penicillin (Hsueh et al., 2005; Jain et al., 2008; Oliver et al., 2007) . The current study showed diminished penicillin susceptibility in one GAS (MIC 0.512 mg ml
21
) isolate, which is in accordance with rising MICs of penicillin (0.25-0.75 mg ml 21 ) in 5 % of isolates in Mexico and 20.6 % in India, attributed to the irrational prescription of antibiotics as has been advocated earlier (Capoor et al., 2006; Hull Vance et al., 2011) . The results of two methods, i.e. the disc diffusion method and the MIC values, did not correlate well with each other's break points, as is described earlier, where even amongst BHS, false susceptibility to macrolides has been identified (Pfaller et al., 2006) .
The difference in antimicrobial resistance worldwide might be due to isolates being collected at different points in time, differences in the site of infection, the age of the patient and the geographical region. Intermediate sensitivity of BHS to various antibiotics can also be accredited to the high use of these antibiotics by physicians. Streptococci show significant resistance to the majority of drugs, which results from changes in targets, active efflux mechanisms and modifying enzymes. The molecular mechanism of antibiotic resistance in GAS is frequently associated with the M phenotype, which harbours particular genes (Smeesters et al., 2010) . The shifts in antibiotic resistance profiles have also been associated with strain replacements happening on larger scales, independent of antibiotic use, in individual regions (Metzgar et al., 2010) .
Since treatment failure, asymptomatic streptococcal carriers, recurrent streptococcal infections and dreaded invasive diseases are important issues to be tackled, the choice of antibiotic(s) is crucial. India is a country with an immense number of plant species possessing medicinal properties and Ayurveda is an intricate traditional holistic system of medicine that originated here. Hence, the antibacterial activity in local spices, herbs, herbal remedies and medicinal plants against streptococci should also be explored (Hull Vance et al., 2011) .
To conclude, variations in the antibiotic susceptibility patterns amongst BHS isolated from a North Indian population were observed, with GAS being highly resistant, compared with GCS and GGS. Antibiotic susceptibility seems to be independent of the source of isolation, as well as the emm type distribution. The antibiotic resistance in the present study may not seem to be clinically a significant issue in our country, but considering its steady rise, continuous monitoring of antibiotic susceptibility for the finalization of an appropriate treatment for streptococcal infections in the local or regional environment is clearly warranted. Also, there is a need for a more controlled use of antibiotics, especially in developing countries like India.
